Adakveo

(crizanlizumab-tmca)
NO BOXED WARNING

Dosage & Administration

Administer 5 mg/kg by intravenous infusion over a period of 30 minutes on Week 0, Week 2, and every 4 weeks thereafter.

See Full Prescribing Information for instructions on preparation and administration.

Get Your Patient on Adakveo

See your patient's specific prior authorization requirements including coverage restrictions and step therapies
Or select your Insurance from the list below:

Adakveo Prescribing Information

Adakveo Financial Assistance Options

Copay savings program

View more

Adakveo PubMed™ News

    Adakveo FAQs